Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Journal of Neurovirology|September 20, 2014
HIV-1 target cells in the CNSSarah B Joseph, Kathryn T Arrildt, Christa B Sturdevant, et al.Journal of Virology|December 6, 2013
Quantification of entry phenotypes of macrophage-tropic HIV-1 across a wide range of CD4 densitiesSarah B Joseph, Kathryn T Arrildt, Adrienne E Swanstrom, et al.Journal of Virology|July 31, 2015
R5 Macrophage-Tropic HIV-1 in the Male Genital TractMaria M Bednar, Blake M Hauser, Li-Hua Ping, et al.Scientific Reports|July 21, 2022
Large-scale application of free energy perturbation calculations for antibody designFangqiang Zhu, Feliza A Bourguet, William F D Bennett, et al.Plos One|January 25, 2024
Differential laboratory passaging of SARS-CoV-2 viral stocks impacts the in vitro assessment of neutralizing antibodiesAram Avila-Herrera, Jeffrey A Kimbrel, Jose Manuel Martí, et al.Viruses|December 23, 2022
Multiple Mutations Associated with Emergent Variants Can Be Detected as Low-Frequency Mutations in Early SARS-CoV-2 Pandemic Clinical SamplesJeffrey Kimbrel, Joseph Moon, Aram Avila-Herrera, et al.Journal of Virology|September 5, 2015
Phenotypic Correlates of HIV-1 Macrophage TropismKathryn T Arrildt, Celia C LaBranche, Sarah B Joseph, et al.Frontiers in Bioinformatics|August 5, 2025
Design of cross-reactive antigens with machine learning and high-throughput experimental evaluationChelsy Chesterman, Thomas Desautels, Luz-Jeannette Sierra, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 6, 2022
A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical modelsGiulietta Maruggi, Corey P Mallett, Jason W Westerbeck, et al.Science Advances|March 28, 2025
Preemptive optimization of a clinical antibody for broad neutralization of SARS-CoV-2 variants and robustness against viral escapeFangqiang Zhu, Saravanan Rajan, Conor F Hayes, et al.Pageof 2